Autori: Szarejko Monika
| Naslov | Lighthouse: melflufen, daratumumab, and dexamethasone versus daratumumab in relapsed/refractory multiple myeloma refractory to an imid and a proteasome inhibitor or with ≥3 prior lines of therapy (Meeting Abstract) |
| Autori | Mateos Maria-Victoria Szarejko Monika Bila Jelena S  Schjesvold Fredrik Spicka Ivan Maisnar Vladimir Jurczyszyn Artur Grudeva-Popova Zhanet Hajek Roman Usenko Hanna Thuresson Marcus Norin Stefan Jarefors Sara Richardson Paul Pour Ludek
|
| Info | CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, (2023), vol. 23 br. , Suppl. 2, str. S200-S201 |
| Ispravka | Web of Science Elečas Rang časopisa |
     |
